Abstract：
Previous studies have proved that healthy behaviors hinder the onset and progression of tumors. Digital therapeutics (DTx), playing a pivotal role in facilitating behavioral adjustments through educational interventions, lifestyle support, and symptom monitoring, contribute to the goal of tumor prevention. We aim to optimize the evaluation of the feasibility and acceptability of DTx for cancer prevention. This involves assessing AITI\'s daily activity rates and user feedback, and comparing changes in behavioral habits and differences in SF-36 before and after the intervention. In a 4-week trial with 57 participants engaging actively, we found both the average daily activity rate and 4-week retention rate at 35 (61.4%). The USE Questionnaire scores (validity, ease of use, acquisition, and satisfaction) ranged from 68.06 to 83.10, indicating AITI\'s user-friendliness and acceptability. Furthermore, positive habit changes were noted among participants in exercise and diet (p < 0.0001), suggesting the effectiveness of the DTx approach in modifying behavioral habits related to physical activity and nutrition. This pilot study underscores the potential of DTx in advancing cancer prevention. However, larger and longer studies are needed to comprehensively assess its impact.
摘要：
先前的研究证明，健康的行为会阻碍肿瘤的发生和发展。数字疗法（DTx），在通过教育干预促进行为调整方面发挥着关键作用，生活方式支持,和症状监测，有助于肿瘤预防的目标。我们旨在优化对DTx预防癌症的可行性和可接受性的评估。这包括评估AITI的日常活动率和用户反馈，并比较干预前后行为习惯的变化和SF-36的差异。在一项为期4周的试验中，57名参与者积极参与，我们发现平均每日活动率和4周保留率为35(61.4%).使用问卷得分(有效性，易用性,收购,和满意度）范围从68.06到83.10，表明AITI的用户友好性和可接受性。此外，参与者在运动和饮食方面注意到积极的习惯变化(p<0.0001)，表明DTx方法在改变与身体活动和营养相关的行为习惯方面的有效性。这项初步研究强调了DTx在推进癌症预防方面的潜力。然而,需要更大和更长的研究来全面评估其影响。
